FDA Drug Recalls

Recalls / Class II

Class IID-0946-2018

Product

fentaNYL 2 mcg/mL, 0.125% ROPivacaine, Fentanyl Citrate, USP 300 mcg, Ropivacaine HCL PF, USP 187.5 mg, 0.9% Sodium Chloride, USP QS 150 mL. Volume: 150 mL. Single dose cassette For: Methodist Dallas Medical Center. By: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054. NDC 15082-278-86

Affected lot / code info
Lot #: 5/14/18 1012 172-27886Y, BUD 6/28/2018.

Why it was recalled

Lack of Assurance of Sterility: Potential leakage of bags.

Recalling firm

Firm
Avella of Deer Valley, Inc. Store 38
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
24416 N 19th Ave, Phoenix, Arizona 85085-1887

Distribution

Quantity
100 cassettes
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2018-06-12
FDA classified
2018-07-19
Posted by FDA
2018-07-25
Terminated
2020-01-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0946-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls